Department of Ophthalmology, University Hospital Mannheim, Mannheim, Germany.
Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Ophthalmic Res. 2024;67(1):654-661. doi: 10.1159/000541481. Epub 2024 Nov 4.
The aim of the study was to investigate the rate of choroidal thinning and Choroidal Vascularity Index (CVI) changes over time in eyes with different stages of age-related macular degeneration (AMD) and control eyes.
Retrospective longitudinal study of 105 eyes with different stages of AMD: non-advanced (n = 46), exudative (n = 28), central complete retinal pigment epithelium and outer retinal atrophy (cRORA) (n = 5) and healthy eyes (n = 26). We evaluated choroidal thickness (CT) and CVI at baseline and during 2-4 years of follow-up. After adjustment for age and sex, we estimated the rate of change per year of CT and CVI in each group. We also performed logistic regression to analyze the relationship between baseline CT and CVI with AMD progression.
The mean age of the included patients was 77.1 years with a mean follow-up of 3.36 years. Healthy eyes had higher baseline CT and CVI values compared to eyes with AMD. Exudative AMD showed a significant annual decrease in subfoveal CT (-5.1% per year vs. -3.5% in controls) and in the temporal and nasal sectors (-5.3% and -6.3%). CVI decreased during follow-up in all study groups, most in eyes with central cRORA (-1.09% per year).
CVI and CT values are reduced in eyes with AMD compared to healthy eyes. Eyes with exudative AMD have the highest annual rate of choroidal thinning, while CVI decreases most in eyes with central cRORA. CT and CVI may aid in a further stratification of AMD progression risk.
本研究旨在探讨不同阶段年龄相关性黄斑变性(AMD)眼和对照组眼中脉络膜变薄和脉络膜血流指数(CVI)随时间的变化率。
回顾性纵向研究了 105 只不同阶段 AMD 眼:非进展期(n = 46)、渗出性(n = 28)、中心完全性视网膜色素上皮和外层视网膜萎缩(cRORA)(n = 5)和健康眼(n = 26)。我们在基线和 2-4 年的随访中评估了脉络膜厚度(CT)和 CVI。在调整年龄和性别后,我们估计了每组 CT 和 CVI 每年的变化率。我们还进行了逻辑回归分析,以分析基线 CT 和 CVI 与 AMD 进展的关系。
纳入患者的平均年龄为 77.1 岁,平均随访时间为 3.36 年。与 AMD 眼相比,健康眼的基线 CT 和 CVI 值较高。渗出性 AMD 表现为黄斑下 CT 每年显著下降(-5.1%,对照组为-3.5%),以及颞部和鼻侧 CT 每年显著下降(-5.3%和-6.3%)。所有研究组的 CVI 在随访期间均下降,以中心 cRORA 眼下降最明显(每年-1.09%)。
与健康眼相比,AMD 眼的 CVI 和 CT 值降低。渗出性 AMD 眼的脉络膜变薄年增长率最高,而中心 cRORA 眼的 CVI 下降幅度最大。CT 和 CVI 可能有助于进一步分层 AMD 进展的风险。